Andrean L. Simons

1.9k total citations
34 papers, 1.5k citations indexed

About

Andrean L. Simons is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Andrean L. Simons has authored 34 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 11 papers in Molecular Biology and 10 papers in Cancer Research. Recurrent topics in Andrean L. Simons's work include Cancer Immunotherapy and Biomarkers (7 papers), Cancer, Hypoxia, and Metabolism (6 papers) and Redox biology and oxidative stress (6 papers). Andrean L. Simons is often cited by papers focused on Cancer Immunotherapy and Biomarkers (7 papers), Cancer, Hypoxia, and Metabolism (6 papers) and Redox biology and oxidative stress (6 papers). Andrean L. Simons collaborates with scholars based in United States, Jordan and Kenya. Andrean L. Simons's co-authors include Douglas R. Spitz, Patricia A. Murphy, Suzanne Hendrich, Min Ah Kang, Toru Ouchi, David Mattson, Iman M. Ahmad, Laurie Love-Homan, Kenneth J. Dornfeld and Mathieu Renouf and has published in prestigious journals such as PLoS ONE, Cancer Research and Journal of Agricultural and Food Chemistry.

In The Last Decade

Andrean L. Simons

33 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andrean L. Simons United States 22 807 358 349 215 199 34 1.5k
Dong Joon Kim China 25 1.4k 1.7× 404 1.1× 320 0.9× 191 0.9× 216 1.1× 58 2.0k
Tao Li China 30 1.3k 1.6× 427 1.2× 315 0.9× 273 1.3× 139 0.7× 149 2.4k
Shireen Vali United States 23 1.2k 1.5× 294 0.8× 497 1.4× 178 0.8× 189 0.9× 67 2.1k
Myeong‐Sok Lee South Korea 26 1.2k 1.5× 272 0.8× 239 0.7× 189 0.9× 160 0.8× 83 2.1k
Rakesh Naidu Malaysia 27 1.2k 1.5× 464 1.3× 484 1.4× 177 0.8× 151 0.8× 91 2.4k
Cristina Sánchez‐de‐Diego Spain 14 842 1.0× 379 1.1× 523 1.5× 132 0.6× 200 1.0× 26 1.8k
Wen‐Sheng Wu Taiwan 22 1.0k 1.3× 360 1.0× 273 0.8× 181 0.8× 97 0.5× 41 1.8k
Alexander A. Chumanevich United States 24 989 1.2× 236 0.7× 419 1.2× 333 1.5× 124 0.6× 46 1.8k
Magdalena Bryś Poland 25 978 1.2× 437 1.2× 333 1.0× 244 1.1× 131 0.7× 105 2.0k
Ravi P. Sahu United States 25 1.2k 1.5× 285 0.8× 416 1.2× 293 1.4× 117 0.6× 89 2.2k

Countries citing papers authored by Andrean L. Simons

Since Specialization
Citations

This map shows the geographic impact of Andrean L. Simons's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrean L. Simons with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrean L. Simons more than expected).

Fields of papers citing papers by Andrean L. Simons

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrean L. Simons. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrean L. Simons. The network helps show where Andrean L. Simons may publish in the future.

Co-authorship network of co-authors of Andrean L. Simons

This figure shows the co-authorship network connecting the top 25 collaborators of Andrean L. Simons. A scholar is included among the top collaborators of Andrean L. Simons based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrean L. Simons. Andrean L. Simons is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xu, Yan, Alexandra McMillan, Nikesh Gupta, et al.. (2025). In situ treatment with a TLR9 agonist virus-like particle to promote immune responses against oral epithelial dysplasia progression. Cancer Immunology Immunotherapy. 74(6). 189–189.
2.
Buchakjian, Marisa R., et al.. (2024). Prognostic Role of Tumor-Infiltrating Lymphocytes in Oral Squamous Cell Carcinoma. BMC Cancer. 24(1). 766–766. 6 indexed citations
3.
Gibson‐Corley, Katherine N., et al.. (2022). Prognostic Role of Combined EGFR and Tumor-Infiltrating Lymphocytes in Oral Squamous Cell Carcinoma. Frontiers in Oncology. 12. 885236–885236. 6 indexed citations
4.
Gibson‐Corley, Katherine N., et al.. (2022). Comparison of Interleukin-1 Ligand Expression by Human Papilloma Virus Status in HNSCCs. Head and Neck Pathology. 16(3). 763–772. 3 indexed citations
5.
Borcherding, Nicholas, Caitlin D. Lemke, Katherine N. Gibson‐Corley, et al.. (2021). The anti-tumor effects of cetuximab in combination with VTX-2337 are T cell dependent. Scientific Reports. 11(1). 1535–1535. 10 indexed citations
6.
Fertig, Elana J., Laura P. Stabile, Julie E. Bauman, et al.. (2019). A preliminary analysis of interleukin-1 ligands as potential predictive biomarkers of response to cetuximab. Biomarker Research. 7(1). 14–14. 7 indexed citations
7.
Rodman, Samuel N., Kathleen A. Ross, Isaac J. Jensen, et al.. (2019). Interleukin-1 alpha increases anti-tumor efficacy of cetuximab in head and neck squamous cell carcinoma. Journal for ImmunoTherapy of Cancer. 7(1). 79–79. 28 indexed citations
8.
Simons, Andrean L., et al.. (2017). Abstract 48: Targeting IL-1 signaling to improve tumor response to erlotinib in HNSCC. Clinical Cancer Research. 23(23_Supplement). 48–48. 1 indexed citations
9.
Love-Homan, Laurie, et al.. (2015). MyD88-Dependent Signaling Decreases the Antitumor Efficacy of Epidermal Growth Factor Receptor Inhibition in Head and Neck Cancer Cells. Cancer Research. 75(8). 1657–1667. 20 indexed citations
10.
Love-Homan, Laurie, et al.. (2015). Upregulated interleukin‐6 expression contributes to erlotinib resistance in head and neck squamous cell carcinoma. Molecular Oncology. 9(7). 1371–1383. 45 indexed citations
11.
Love-Homan, Laurie, et al.. (2013). EGFR Inhibition Induces Proinflammatory Cytokines via NOX4 in HNSCC. Molecular Cancer Research. 11(12). 1574–1584. 45 indexed citations
12.
Simons, Andrean L., Ping Lü, Katherine N. Gibson‐Corley, et al.. (2013). The Justy mutant mouse strain produces a spontaneous murine model of salivary gland cancer with myoepithelial and basal cell differentiation. Laboratory Investigation. 93(6). 711–719. 11 indexed citations
13.
Schickling, Brandon, Laurie Love-Homan, Adam J. Case, et al.. (2013). NOX4 mediates cytoprotective autophagy induced by the EGFR inhibitor erlotinib in head and neck cancer cells. Toxicology and Applied Pharmacology. 272(3). 736–745. 53 indexed citations
14.
Love-Homan, Laurie, et al.. (2012). Susceptibility of Human Head and Neck Cancer Cells to Combined Inhibition of Glutathione and Thioredoxin Metabolism. PLoS ONE. 7(10). e48175–e48175. 63 indexed citations
15.
Du, Juan, Andrean L. Simons, Justin Moser, et al.. (2012). Regulation of pancreatic cancer growth by superoxide. Molecular Carcinogenesis. 52(7). 555–567. 36 indexed citations
16.
Kang, Min Ah, et al.. (2012). DNA damage induces reactive oxygen species generation through the H2AX-Nox1/Rac1 pathway. Cell Death and Disease. 3(1). e249–e249. 255 indexed citations
17.
Fath, Melissa A., Anne R. Diers, Nükhet Aykin‐Burns, et al.. (2009). Mitochondrial electron transport chain blockers enhance 2-deoxy-D-glucose induced oxidative stress and cell killing in human colon carcinoma cells. Cancer Biology & Therapy. 8(13). 1228–1236. 54 indexed citations
18.
Mattson, David, Iman M. Ahmad, Nükhet Aykin‐Burns, et al.. (2008). Cisplatin combined with zidovudine enhances cytotoxicity and oxidative stress in human head and neck cancer cells via a thiol-dependent mechanism. Free Radical Biology and Medicine. 46(2). 232–237. 46 indexed citations
19.
Simons, Andrean L., Melissa A. Fath, David Mattson, et al.. (2007). Enhanced Response of Human Head and Neck Cancer Xenograft Tumors to Cisplatin Combined With 2-Deoxy-d-Glucose Correlates With Increased 18F-FDG Uptake as Determined by PET Imaging. International Journal of Radiation Oncology*Biology*Physics. 69(4). 1222–1230. 53 indexed citations
20.
Langat‐Thoruwa, Caroline, et al.. (2002). A Simple Synthesis of 7,4‘-Dihydroxy-6-methoxyisoflavone, Glycitein, the Third Soybean Isoflavone. Journal of Natural Products. 66(1). 149–151. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dong Joon Kim Breakdown of academic impact, for papers by Tao Li Breakdown of academic impact, for papers by Shireen Vali Breakdown of academic impact, for papers by Myeong‐Sok Lee Breakdown of academic impact, for papers by Rakesh Naidu Breakdown of academic impact, for papers by Cristina Sánchez‐de‐Diego Breakdown of academic impact, for papers by Wen‐Sheng Wu Breakdown of academic impact, for papers by Alexander A. Chumanevich Breakdown of academic impact, for papers by Magdalena Bryś Breakdown of academic impact, for papers by Ravi P. Sahu
Rankless by CCL
2026